Highlights,Oppenheimer Holdings hits a new twelve-month high during mid-day trading,Maintains strong average performance above both short- and long-term moving levels,Solid quarterly and consistent ...

Sarepta Therapeutics ( NASDAQ: SRPT) was upgraded to Neutral from Underweight at J.P. Morgan as it sees FDA's Elevidys hold removal recommendation in ambulatory patients as a clear win.

Visa and Mastercard are expected to report higher quarterly profits this week on steady consumer spending, and analysts will ...